Results 211 to 220 of about 22,694 (264)
Some of the next articles are maybe not open access.
Hormone withdrawal symptoms in oral contraceptive users
Obstetrics & Gynecology, 2000To measure the timing, frequency, and severity of hormone-related symptoms in oral contraceptive (OC) users, specifically to compare active-pill with hormone-free intervals.Using daily diaries, women recorded pelvic pain, bleeding, headaches, analgesic use, nausea or vomiting, bloating or swelling, and breast tenderness during active-pill intervals and
P J, Sulak +4 more
openaire +2 more sources
HORMONE BALANCE OF ORAL CONTRACEPTIVES
BJOG: An International Journal of Obstetrics & Gynaecology, 1967Endometrial changes before and during treatment with 28 oral contraceptive formulations are described. The oral contraceptive agents (OCAs) were classified into 3 groups according to their endometrial effect. The first group was comprised of combined tablets which had an overall strongly progestagenic effect.
openaire +2 more sources
Oral hormonal contraception in adolescents
Therapeutische Umschau, 2001Die neuen Präparate, welche zur hormonalen Kontrazeption gebraucht werden, sind wirksam, sicher und besitzen weniger unerwünschte Nebenwirkungen als die älteren Formulierungen. Die Inzidenz ernsthafter Nebenwirkungen ist niedrig, vor allem, wenn dies mit dem durch eine Schwangerschaft bedingten Risiko für lebensbedrohliche Komplikationen verglichen ...
Marco Butarelli +3 more
openaire +1 more source
Nurse Prescribing, 2017
Humans have long sought to control their own fertility. One relatively recent but widespread method of contraception is the oral administration of, usually, synthetic hormones or analogues to modify the female reproductive cycle. This article will discuss the mechanisms, correct uses and precautions involved in the safe and effective use of such ...
openaire +1 more source
Humans have long sought to control their own fertility. One relatively recent but widespread method of contraception is the oral administration of, usually, synthetic hormones or analogues to modify the female reproductive cycle. This article will discuss the mechanisms, correct uses and precautions involved in the safe and effective use of such ...
openaire +1 more source
The Future of Oral Hormonal Contraception
1999Each second, the world population increases by three newborn babies (98 million per year); nine out of ten are born in developing countries. In 2050, the total population will be 12.5 billion instead of the 6 billion of today. No war, no disease, but only access to and the acceptance of effective methods of fertility control can stop the growth of the ...
Thomas Rabe, Benno Runnebaum
openaire +1 more source
Non-oral hormonal contraception
Current Obstetrics & Gynaecology, 2003Summary This review will consider the non-oral hormonal contraceptive methods—combined injectables, intramuscular and subcutaneous progestogen-only injectables, progestogen implants, the Levonorgestrel intrauterine system, transdermal patches and the, as yet unavailable, vaginal Nuvaring.
openaire +1 more source
Acta medica portuguesa, 2001
The authors focus on the main goals of hormonal contraception with special attention to its benefits regarding some pathological situations. Post coital, post partum and adolescent hormonal contraception are reviewed in detail. The authors also point out the contraindications to its prescription.
openaire +1 more source
The authors focus on the main goals of hormonal contraception with special attention to its benefits regarding some pathological situations. Post coital, post partum and adolescent hormonal contraception are reviewed in detail. The authors also point out the contraindications to its prescription.
openaire +1 more source
Oral contraceptives, hormone therapy and cardiovascular risk
Climacteric, 2008Soon after combined estrogen/progestogen oral contraceptives (COCs) were introduced in the 1950s, it was established that they cause venous thromboembolism (VTE), that the risk is related to estrogen dose, and that COCs also increase the risk of myocardial infarction among female smokers over age 35. Stroke risk is also increased.
openaire +2 more sources
FIBROCYSTIC DISEASE IN WOMEN RECEIVING ORAL CONTRACEPTIVE HORMONES
Obstetrical & Gynecological Survey, 1970To assess the effect of oral contraceptive hormones on breast tissue in women with fibrocystic disease a group of 25 women who had been using oral contraceptives and had developed this disease were compared with a group of 25 women who had fibrocystic disease but had never used oral contraceptives. No single oral contraceptive preparation was studied.
openaire +2 more sources
[New progestins in oral hormonal contraceptives].
Archives of gynecology and obstetrics, 1989Three new progestins with a high gestagenic potency have been developed as derivatives of the levonorgestrel (in brackets: biological active substance in the human): desogestrel (3-keto-desogestrel), norgestimate (norgestimate), gestodene (gestodene). In combination with low dosages of ethinylestradiol (30-35 micrograms) an excessive steroid overload ...
B, Runnebaum, T, Rabe
openaire +1 more source